BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 772418)

  • 1. The pancreatic beta-cell recognition of insulin secretagogues. XII. Insulin release in response to halogenated hexosamines.
    Hellman B; Idahl LA; Lernmark A; Täljedal IB; Thomas EW
    Mol Pharmacol; 1976 Mar; 12(2):208-16. PubMed ID: 772418
    [No Abstract]   [Full Text] [Related]  

  • 2. The hexosamine biosynthesis pathway regulates insulin secretion via protein glycosylation in mouse islets.
    Zraika S; Dunlop M; Proietto J; Andrikopoulos S
    Arch Biochem Biophys; 2002 Sep; 405(2):275-9. PubMed ID: 12220542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-induced cycles of insulin release can be resolved into distinct periods of secretory activity.
    Bergsten P; Hellman B
    Biochem Biophys Res Commun; 1993 May; 192(3):1182-8. PubMed ID: 8507191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolbutamide stimulation of 45Ca fluxes in microdissected pancreatic islets rich in beta-cells.
    Hellman B
    Mol Pharmacol; 1981 Jul; 20(1):83-8. PubMed ID: 7027024
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of biguanides on insulin release from isolated pancreatic islets.
    di Carlo A; Marchetti P; Giannarelli R; Villani G; Masiello P; Gregorio F; Masoni A; Brunetti P; Navalesi R
    Diabete Metab; 1992; 18(6):470-2. PubMed ID: 1297607
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulsatile insulin release and electrical activity from single ob/ob mouse islets of Langerhans.
    Rosario LM; Atwater I; Scott AM
    Adv Exp Med Biol; 1986; 211():413-25. PubMed ID: 3300197
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of quinaldic acid and its relatives on insulin-release from isolated Langerhans islets.
    Okamoto H
    Acta Vitaminol Enzymol; 1975; 29(1-6):227-31. PubMed ID: 801703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of priming with D-glucose on insulin secretion from rat pancreatic islets: increased responsiveness to other secretagogues.
    Grill V; Rundfeldt M
    Endocrinology; 1979 Oct; 105(4):980-7. PubMed ID: 89958
    [No Abstract]   [Full Text] [Related]  

  • 9. Actin filament formation in pancreatic beta-cells during glucose stimulation of insulin secretion.
    Swanston-Flatt SK; Carlsson L; Gylfe E
    FEBS Lett; 1980 Aug; 117(1):299-302. PubMed ID: 6997078
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective effects of secretagogues on insulin secretion: a mathematical model.
    Cohen DM; Pek SB
    Comput Biol Med; 1984; 14(2):191-207. PubMed ID: 6373118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Threshold for glucose-stimulated insulin secretion in pancreatic islets of genetically obese (ob/ob) mice is abnormally low.
    Chen NG; Tassava TM; Romsos DR
    J Nutr; 1993 Sep; 123(9):1567-74. PubMed ID: 8360782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pancreatic beta-cell recognition of insulin secretagogues. XIII. Effects of sulphydryl reagents on cyclic AMP.
    Hellman B; Idahl LA; Lernmark A; Täljedal IB
    Biochim Biophys Acta; 1974 Nov; 372(1):127-34. PubMed ID: 4371860
    [No Abstract]   [Full Text] [Related]  

  • 13. Intermediary metabolism and insulin secretion from isolated rat islets of Langerhans.
    Zawalich WS
    Diabetes; 1979 Mar; 28(3):252-62. PubMed ID: 376378
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of goldthioglucose on hormone secretion of pancreatic rat islets in vitro.
    Hahn HJ; Gottschling HD; Butter R
    Endokrinologie; 1980 Dec; 76(3):365-70. PubMed ID: 6781882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phorbol myristate acetate: effect of a tumor promoter on insulin release from isolated rat islets of Langerhans.
    Virji MA; Steffes MW; Estensen RD
    Endocrinology; 1978 Mar; 102(3):706-11. PubMed ID: 369826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets.
    Lalloyer F; Vandewalle B; Percevault F; Torpier G; Kerr-Conte J; Oosterveer M; Paumelle R; Fruchart JC; Kuipers F; Pattou F; Fiévet C; Staels B
    Diabetes; 2006 Jun; 55(6):1605-13. PubMed ID: 16731822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-antagonists and islet function-XII. Comparison between nifedipine and chemically related drugs.
    Malaisse WJ; Sener A
    Biochem Pharmacol; 1981 May; 30(10):1039-41. PubMed ID: 7020702
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets.
    Lau T; Carlsson PO; Leung PS
    Diabetologia; 2004 Feb; 47(2):240-8. PubMed ID: 14722647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pancreatic -cell recognition of insulin secretagogues. I. Transport of mannoheptulose and the dynamics of insulin release.
    Hellman B; Idahl LA; Lernmark A; Sehlin J; Simon E; Täljedal IB
    Mol Pharmacol; 1972 Jan; 8(1):1-7. PubMed ID: 4551472
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium and pancreatic beta-cell function: glucose stimulation uptake of lanthanum-displaceable 45-Ca from low or normal calcium-containing media.
    Hellman B; Gylfe E
    Horm Metab Res; 1978 Jan; 10(1):29-31. PubMed ID: 344180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.